⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Is Boehringer Ingelheim Pharmaceuticals recalled?

Official U.S. agency records list 1 recall involving Boehringer Ingelheim Pharmaceuticals in the last 12 months, most recently on 2026-07-08. Check each official notice for the exact products, lot codes and dates affected.

Check a lot code, UPC or model number

This is not a guarantee; check the official notice.

Recalls (1)

Boehringer Ingelheim Pharmaceuticals, Inc.: Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Dist
DrugsFDA (drug) · 2026-07-08 · Class II
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.